Loading…

Pathogenesis of Myocardial Ischemia-Reperfusion Injury and Rationale for Therapy

Since the initial description of the phenomenon by Jennings et al 50 years ago, our understanding of the underlying mechanisms of reperfusion injury has grown significantly. Its pathogenesis reflects the confluence of multiple pathways, including ion channels, reactive oxygen species, inflammation,...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2010-08, Vol.106 (3), p.360-368
Main Authors: Turer, Aslan T., MD, MHS, Hill, Joseph A., MD, PhD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c614t-aa53d69fbb9a7743303cceb8ce0b2c7da4548d1bb261735755e21cd0186b83bd3
cites cdi_FETCH-LOGICAL-c614t-aa53d69fbb9a7743303cceb8ce0b2c7da4548d1bb261735755e21cd0186b83bd3
container_end_page 368
container_issue 3
container_start_page 360
container_title The American journal of cardiology
container_volume 106
creator Turer, Aslan T., MD, MHS
Hill, Joseph A., MD, PhD
description Since the initial description of the phenomenon by Jennings et al 50 years ago, our understanding of the underlying mechanisms of reperfusion injury has grown significantly. Its pathogenesis reflects the confluence of multiple pathways, including ion channels, reactive oxygen species, inflammation, and endothelial dysfunction. The purposes of this review are to examine the current state of understanding of ischemia-reperfusion injury, as well as to highlight recent interventions aimed at this heretofore elusive target. In conclusion, despite its complexity our ongoing efforts to mitigate this form of injury should not be deterred, because nearly 2 million patients annually undergo either spontaneous (in the form of acute myocardial infarction) or iatrogenic (in the context of cardioplegic arrest) ischemia-reperfusion.
doi_str_mv 10.1016/j.amjcard.2010.03.032
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2957093</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0002914910007812</els_id><sourcerecordid>2095637481</sourcerecordid><originalsourceid>FETCH-LOGICAL-c614t-aa53d69fbb9a7743303cceb8ce0b2c7da4548d1bb261735755e21cd0186b83bd3</originalsourceid><addsrcrecordid>eNqFUk1v1DAQtRCIbhd-AijiwimLPxInuRShCspKRVSlnK2JPek6JPFiJ5Xy73HYZQW9II1ke_zmeZ7fEPKK0Q2jTL5rN9C3GrzZcBpzVMTgT8iKlUWVsoqJp2RFKeVpxbLqjJyH0MYjY7l8Ts44lZngmVyRmxsYd-4eBww2JK5JvsxuYbXQJdugd9hbSG9xj76ZgnVDsh3ayc8JDCa5hTFmoMOkcT6526GH_fyCPGugC_jyuK7J908f7y4_p9dfr7aXH65TLVk2pgC5MLJq6rqCosiEoEJrrEuNtOa6MJDlWWlYXXPJCpEXeY6caUNZKetS1EasycWBdz_VPRqNw-ihU3tve_CzcmDVvzeD3al796B4lRe0EpHg7ZHAu58ThlH1NmjsOhjQTUEVIqM0NiYj8s0jZOsmH4X_BkWAjALWJD-AtHcheGxOrTCqFsdUq46OqcUxRUUMHute_63jVPXHogh4fwBg_M0Hi14FbXHQaKxHPSrj7H-fuHjEoDs7WA3dD5wxnMQwFbii6tsyNsvUsLgpSsbFL5Zkv6s</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>734363674</pqid></control><display><type>article</type><title>Pathogenesis of Myocardial Ischemia-Reperfusion Injury and Rationale for Therapy</title><source>ScienceDirect Journals</source><creator>Turer, Aslan T., MD, MHS ; Hill, Joseph A., MD, PhD</creator><creatorcontrib>Turer, Aslan T., MD, MHS ; Hill, Joseph A., MD, PhD</creatorcontrib><description>Since the initial description of the phenomenon by Jennings et al 50 years ago, our understanding of the underlying mechanisms of reperfusion injury has grown significantly. Its pathogenesis reflects the confluence of multiple pathways, including ion channels, reactive oxygen species, inflammation, and endothelial dysfunction. The purposes of this review are to examine the current state of understanding of ischemia-reperfusion injury, as well as to highlight recent interventions aimed at this heretofore elusive target. In conclusion, despite its complexity our ongoing efforts to mitigate this form of injury should not be deterred, because nearly 2 million patients annually undergo either spontaneous (in the form of acute myocardial infarction) or iatrogenic (in the context of cardioplegic arrest) ischemia-reperfusion.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2010.03.032</identifier><identifier>PMID: 20643246</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Cardiac Surgical Procedures - adverse effects ; Cardiology ; Cardiovascular ; Heart Arrest, Induced - adverse effects ; Humans ; Ischemia ; Myocardial Infarction - physiopathology ; Myocardial Infarction - therapy ; Myocardial Reperfusion Injury - physiopathology ; Myocardial Reperfusion Injury - prevention &amp; control ; Pathogenesis ; Risk Factors</subject><ispartof>The American journal of cardiology, 2010-08, Vol.106 (3), p.360-368</ispartof><rights>Elsevier Inc.</rights><rights>2010 Elsevier Inc.</rights><rights>Copyright (c) 2010 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Sequoia S.A. Aug 1, 2010</rights><rights>2010 Excerpta Medica, Inc. All rights reserved. 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c614t-aa53d69fbb9a7743303cceb8ce0b2c7da4548d1bb261735755e21cd0186b83bd3</citedby><cites>FETCH-LOGICAL-c614t-aa53d69fbb9a7743303cceb8ce0b2c7da4548d1bb261735755e21cd0186b83bd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20643246$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Turer, Aslan T., MD, MHS</creatorcontrib><creatorcontrib>Hill, Joseph A., MD, PhD</creatorcontrib><title>Pathogenesis of Myocardial Ischemia-Reperfusion Injury and Rationale for Therapy</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>Since the initial description of the phenomenon by Jennings et al 50 years ago, our understanding of the underlying mechanisms of reperfusion injury has grown significantly. Its pathogenesis reflects the confluence of multiple pathways, including ion channels, reactive oxygen species, inflammation, and endothelial dysfunction. The purposes of this review are to examine the current state of understanding of ischemia-reperfusion injury, as well as to highlight recent interventions aimed at this heretofore elusive target. In conclusion, despite its complexity our ongoing efforts to mitigate this form of injury should not be deterred, because nearly 2 million patients annually undergo either spontaneous (in the form of acute myocardial infarction) or iatrogenic (in the context of cardioplegic arrest) ischemia-reperfusion.</description><subject>Cardiac Surgical Procedures - adverse effects</subject><subject>Cardiology</subject><subject>Cardiovascular</subject><subject>Heart Arrest, Induced - adverse effects</subject><subject>Humans</subject><subject>Ischemia</subject><subject>Myocardial Infarction - physiopathology</subject><subject>Myocardial Infarction - therapy</subject><subject>Myocardial Reperfusion Injury - physiopathology</subject><subject>Myocardial Reperfusion Injury - prevention &amp; control</subject><subject>Pathogenesis</subject><subject>Risk Factors</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqFUk1v1DAQtRCIbhd-AijiwimLPxInuRShCspKRVSlnK2JPek6JPFiJ5Xy73HYZQW9II1ke_zmeZ7fEPKK0Q2jTL5rN9C3GrzZcBpzVMTgT8iKlUWVsoqJp2RFKeVpxbLqjJyH0MYjY7l8Ts44lZngmVyRmxsYd-4eBww2JK5JvsxuYbXQJdugd9hbSG9xj76ZgnVDsh3ayc8JDCa5hTFmoMOkcT6526GH_fyCPGugC_jyuK7J908f7y4_p9dfr7aXH65TLVk2pgC5MLJq6rqCosiEoEJrrEuNtOa6MJDlWWlYXXPJCpEXeY6caUNZKetS1EasycWBdz_VPRqNw-ihU3tve_CzcmDVvzeD3al796B4lRe0EpHg7ZHAu58ThlH1NmjsOhjQTUEVIqM0NiYj8s0jZOsmH4X_BkWAjALWJD-AtHcheGxOrTCqFsdUq46OqcUxRUUMHute_63jVPXHogh4fwBg_M0Hi14FbXHQaKxHPSrj7H-fuHjEoDs7WA3dD5wxnMQwFbii6tsyNsvUsLgpSsbFL5Zkv6s</recordid><startdate>20100801</startdate><enddate>20100801</enddate><creator>Turer, Aslan T., MD, MHS</creator><creator>Hill, Joseph A., MD, PhD</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TS</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20100801</creationdate><title>Pathogenesis of Myocardial Ischemia-Reperfusion Injury and Rationale for Therapy</title><author>Turer, Aslan T., MD, MHS ; Hill, Joseph A., MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c614t-aa53d69fbb9a7743303cceb8ce0b2c7da4548d1bb261735755e21cd0186b83bd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Cardiac Surgical Procedures - adverse effects</topic><topic>Cardiology</topic><topic>Cardiovascular</topic><topic>Heart Arrest, Induced - adverse effects</topic><topic>Humans</topic><topic>Ischemia</topic><topic>Myocardial Infarction - physiopathology</topic><topic>Myocardial Infarction - therapy</topic><topic>Myocardial Reperfusion Injury - physiopathology</topic><topic>Myocardial Reperfusion Injury - prevention &amp; control</topic><topic>Pathogenesis</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Turer, Aslan T., MD, MHS</creatorcontrib><creatorcontrib>Hill, Joseph A., MD, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Physical Education Index</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Turer, Aslan T., MD, MHS</au><au>Hill, Joseph A., MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pathogenesis of Myocardial Ischemia-Reperfusion Injury and Rationale for Therapy</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2010-08-01</date><risdate>2010</risdate><volume>106</volume><issue>3</issue><spage>360</spage><epage>368</epage><pages>360-368</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>Since the initial description of the phenomenon by Jennings et al 50 years ago, our understanding of the underlying mechanisms of reperfusion injury has grown significantly. Its pathogenesis reflects the confluence of multiple pathways, including ion channels, reactive oxygen species, inflammation, and endothelial dysfunction. The purposes of this review are to examine the current state of understanding of ischemia-reperfusion injury, as well as to highlight recent interventions aimed at this heretofore elusive target. In conclusion, despite its complexity our ongoing efforts to mitigate this form of injury should not be deterred, because nearly 2 million patients annually undergo either spontaneous (in the form of acute myocardial infarction) or iatrogenic (in the context of cardioplegic arrest) ischemia-reperfusion.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>20643246</pmid><doi>10.1016/j.amjcard.2010.03.032</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0002-9149
ispartof The American journal of cardiology, 2010-08, Vol.106 (3), p.360-368
issn 0002-9149
1879-1913
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2957093
source ScienceDirect Journals
subjects Cardiac Surgical Procedures - adverse effects
Cardiology
Cardiovascular
Heart Arrest, Induced - adverse effects
Humans
Ischemia
Myocardial Infarction - physiopathology
Myocardial Infarction - therapy
Myocardial Reperfusion Injury - physiopathology
Myocardial Reperfusion Injury - prevention & control
Pathogenesis
Risk Factors
title Pathogenesis of Myocardial Ischemia-Reperfusion Injury and Rationale for Therapy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T03%3A49%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pathogenesis%20of%20Myocardial%20Ischemia-Reperfusion%20Injury%20and%20Rationale%20for%20Therapy&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Turer,%20Aslan%20T.,%20MD,%20MHS&rft.date=2010-08-01&rft.volume=106&rft.issue=3&rft.spage=360&rft.epage=368&rft.pages=360-368&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/j.amjcard.2010.03.032&rft_dat=%3Cproquest_pubme%3E2095637481%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c614t-aa53d69fbb9a7743303cceb8ce0b2c7da4548d1bb261735755e21cd0186b83bd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=734363674&rft_id=info:pmid/20643246&rfr_iscdi=true